These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 21160410)

  • 1. HIV-1 infection and cognitive impairment in the cART era: a review.
    Schouten J; Cinque P; Gisslen M; Reiss P; Portegies P
    AIDS; 2011 Mar; 25(5):561-75. PubMed ID: 21160410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Wright EJ
    Curr Opin HIV AIDS; 2009 Sep; 4(5):447-52. PubMed ID: 20048710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.
    Taiwo B; Hicks C; Eron J
    J Antimicrob Chemother; 2010 Jun; 65(6):1100-7. PubMed ID: 20348088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive outcomes in pediatric HIV.
    Willen EJ
    Ment Retard Dev Disabil Res Rev; 2006; 12(3):223-8. PubMed ID: 17061290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and virological correlation between the cerebrospinal fluid and blood of HIV-infected children].
    Sáez-Llorens X; Castrejón de Wong MC; Castaño E; de Suman O; Báez de Ulloa C; Redondo W; Espino M
    Rev Med Panama; 2001; 26():13-8. PubMed ID: 16161718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report.
    Schifitto G; Peterson DR; Zhong J; Ni H; Cruttenden K; Gaugh M; Gendelman HE; Boska M; Gelbard H
    Neurology; 2006 Mar; 66(6):919-21. PubMed ID: 16510768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HIV-1 cognitive and motor syndrome].
    Mussa M; Preux PM; Debrock C; Chazot-Balcon M; Melaku Z; Druet-Cabanac M; Kayembe K; Dumas M
    Sante; 1997; 7(3):187-93. PubMed ID: 9296810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 infection and neurocognitive impairment in the current era.
    del Palacio M; Alvarez S; Muñoz-Fernández MÁ
    Rev Med Virol; 2012 Jan; 22(1):33-45. PubMed ID: 21990255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment.
    Mellgren A; Antinori A; Cinque P; Price RW; Eggers C; Hagberg L; Gisslén M
    Antivir Ther; 2005; 10(6):701-7. PubMed ID: 16218168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus dementia patients in Africa: How many? Who cares? And where to from here?
    Birbeck GL
    J Neurovirol; 2005; 11 Suppl 3():30-3. PubMed ID: 16540452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates.
    Goodkin K; Wilkie FL; Concha M; Asthana D; Shapshak P; Douyon R; Fujimura RK; LoPiccolo C
    Neuroimaging Clin N Am; 1997 Aug; 7(3):561-79. PubMed ID: 9376968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands.
    Portegies P; Enting RH; de Gans J; Algra PR; Derix MM; Lange JM; Goudsmit J
    AIDS; 1993 May; 7(5):669-75. PubMed ID: 8318174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 associated dementia: symptoms and causes.
    Ghafouri M; Amini S; Khalili K; Sawaya BE
    Retrovirology; 2006 May; 3():28. PubMed ID: 16712719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection of the central nervous system: clinical features and neuropathogenesis.
    Boissé L; Gill MJ; Power C
    Neurol Clin; 2008 Aug; 26(3):799-819, x. PubMed ID: 18657727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuropsychological evaluation of the cognitive deficits in infection by human immunodeficiency virus type 1 (HIV-1)].
    Clemente-Millana L; Portellano JA
    Rev Neurol; 2000 Dec 16-31; 31(12):1192-201. PubMed ID: 11205557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
    Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
    Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Impairment and Persistent CNS Injury in Treated HIV.
    Chan P; Hellmuth J; Spudich S; Valcour V
    Curr HIV/AIDS Rep; 2016 Aug; 13(4):209-17. PubMed ID: 27188299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.
    McArthur JC; McDermott MP; McClernon D; St Hillaire C; Conant K; Marder K; Schifitto G; Selnes OA; Sacktor N; Stern Y; Albert SM; Kieburtz K; deMarcaida JA; Cohen B; Epstein LG
    Arch Neurol; 2004 Nov; 61(11):1687-96. PubMed ID: 15534180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.